Skip to Content

93/11 (Pantoprazole sodium delayed-release 20 mg)

Pill imprint 93/11 has been identified as Pantoprazole sodium delayed-release 20 mg.

Pantoprazole is used in the treatment of barrett's esophagus; erosive esophagitis; dumping syndrome; gastritis/duodenitis; gerd (and more), and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Pantoprazole 20 mg is not a controlled substance under the Controlled Substance Act (CSA).

Pantoprazole sodium delayed-release 20 mg 93/11
Pantoprazole sodium delayed-release 20 mg 93/11  Front
Pantoprazole sodium delayed-release 20 mg 93/11  Back
Pantoprazole sodium delayed-release 20 mg 93/11
Pantoprazole sodium delayed-release
20 mg
8.00 mm
Elliptical / Oval
Prescription only
Drug Class:
Proton pump inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Teva Pharmaceuticals USA
National Drug Code (NDC):
Inactive Ingredients:
calcium carbonate
calcium stearate
D&C Yellow No. 10
aluminum oxide
FD&C Yellow No. 6
hypromellose 2910 (15 mPa.s)
ferrosoferric oxide
ferric oxide yellow
lactose monohydrate
low substituted hydroxypropyl cellulose
methacrylic acid - ethyl acrylate copolymer (1:1) type a
microcrystalline cellulose
polyethylene glycol 4000
propylene glycol
sodium carbonate
stearic acid
magnesium silicate
titanium dioxide
triethyl citrate

View Details Print Page Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.